Thursday October 18, 2018 04:06

Heathcare Press Release : 04 Oct 2018

Veloce BioPharma Announces Positive Phase 2b Study Results for VBP-926 (Topical Povidone-Iodine in Heathcare—04 Oct 18

Veloce BioPharma Announces Positive Phase 2b Study Results for VBP-926 (Topical Povidone-Iodine in a Novel Non-Aqueous Vehicle) in Subjects with Chemotherapy-Associated Paronychia - Veloce BioPharma's VBP-926 (Povidone-Iodine) Demonstrates Statistically